Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study

Erratum to: Pituitary DOI 10.1007/s11102-014-0585-6

An error appears twice in the published article: in the first row, second column of Tables 4 and 5. Both columns were labelled: Extension baseline. The authors would like to note that this text is incorrect; both column labels have been corrected to: Core baseline.

Table 4 Overall shift in glucose from core baseline to last available value up to month 26

Table 5 Overall shift in HbA_1c from core baseline to last available value up to month 26